Lundbeck
HLUN-B.CO
#2744
Rank
NZ$10.97 B
Marketcap
NZ$11.06
Share price
-0.80%
Change (1 day)
20.42%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): NZ$1.29

According to Lundbeck's latest financial reports the company's current EPS (TTM) is NZ$1.30. In 2025 the company made an earnings per share (EPS) of NZ$0.87 an increase over its 2024 EPS that were of NZ$0.76.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$1.2947.58%
2025NZ$0.8714.5%
2024NZ$0.7629.29%
2023NZ$0.5923.09%
2022NZ$0.4837.26%
2021NZ$0.35-84.61%
2020NZ$2.27-24.61%
2019NZ$3.01-42.06%
2018NZ$5.2040.7%
2017NZ$3.70146.26%
2016NZ$1.50-120.48%
2015NZ-$7.333231.32%
2014NZ-$0.22-115.78%
2013NZ$1.39-23.36%
2012NZ$1.82-48.01%
2011NZ$3.50-9.68%
2010NZ$3.8813.72%
2009NZ$3.4124.32%
2008NZ$2.74-6.05%
2007NZ$2.9281.77%
2006NZ$1.60-16.76%
2005NZ$1.93-17.58%
2004NZ$2.34